|
Video: What is a Stock Split?
|
|
Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Co. is developing and advancing its primary clinical phage candidate for Pseudomonas aeruginosa. Co. is also developing a phage product candidate for Staphylococcus aureus for the treatment of S. aureus bacteremia. In addition, Co. has phage development efforts underway to target other indications including non-cystic fibrosis bronchiectasis, prosthetic joint infections and hospitalized pneumonia. According to our ARMP split history records, Armata Pharmaceuticals has had 1 split. | |
|
Armata Pharmaceuticals (ARMP) has 1 split in our ARMP split history database. The split for ARMP took place on May 10, 2019. This was a 1 for 14 reverse split, meaning for each 14 shares of ARMP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 71.4285714285714 share position following the split.
When a company such as Armata Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ARMP split history from start to finish, an original position size of 1000 shares would have turned into 71.4285714285714 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Armata Pharmaceuticals shares, starting with a $10,000 purchase of ARMP, presented on a split-history-adjusted basis factoring in the complete ARMP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$7.98 |
|
End price/share: |
$2.50 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-68.67% |
|
Average Annual Total Return: |
-10.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,133.21 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
05/10/2019 | 1 for 14 |
|
|